Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | KB-GDT-01 |
Synonyms | |
Therapy Description |
Limited information is available on KB-GDT-01, a putative cell therapy comprising allogeneic gamma delta T-cells (Jan 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
KB-GDT-01 | Deltacel | Limited information is available on KB-GDT-01, a putative cell therapy comprising allogeneic gamma delta T-cells (Jan 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06069570 | Phase I | KB-GDT-01 | Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Stage 4 Metastatic NSCLC | Recruiting | USA | 0 |